Echo Lake Capital Increase Offer to Acquire Quince Therapeutics, for $1.80/Share
Portfolio Pulse from Benzinga Newsdesk
Echo Lake Capital has issued a revised proposal to acquire Quince Therapeutics, Inc. (NASDAQ:QNCX) for $1.80 per share in cash plus a CVR to receive 85% of the future net proceeds from the Lighthouse Pharmaceutical transaction.
July 13, 2023 | 12:06 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Echo Lake Capital's revised proposal to acquire Quince Therapeutics could potentially increase the stock price of QNCX in the short term.
The revised proposal from Echo Lake Capital to acquire Quince Therapeutics at $1.80 per share, which is likely higher than the current trading price, could potentially increase the stock price of QNCX in the short term. Additionally, the CVR to receive 85% of the future net proceeds from the Lighthouse Pharmaceutical transaction could further increase the value of the stock.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100